BlackRock Fund Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.43M | Buy |
3,978
+761
| +24% | +$464K | ﹤0.01% | 3127 |
|
|
2016
Q3 | $2.3M | Buy |
3,217
+518
| +19% | +$370K | ﹤0.01% | 3129 |
|
|
2016
Q2 | $1.96M | Buy |
2,699
+2,454
| +1,002% | +$1.78M | ﹤0.01% | 3195 |
|
|
2016
Q1 | $146K | Sell |
245
-19
| -7% | -$11.3K | ﹤0.01% | 3566 |
|
|
2015
Q4 | $151K | Buy |
264
+10
| +4% | +$5.72K | ﹤0.01% | 3627 |
|
|
2015
Q3 | $142K | Sell |
254
-7
| -3% | -$3.91K | ﹤0.01% | 3602 |
|
|
2015
Q2 | $207K | Buy |
261
+32
| +14% | +$25.4K | ﹤0.01% | 3521 |
|
|
2015
Q1 | $191K | Sell |
229
-16
| -7% | -$13.3K | ﹤0.01% | 3501 |
|
|
2014
Q4 | $176K | Buy |
245
+18
| +8% | +$12.9K | ﹤0.01% | 3517 |
|
|
2014
Q3 | $158K | Sell |
227
-17
| -7% | -$11.8K | ﹤0.01% | 3548 |
|
|
2014
Q2 | $206K | Sell |
244
-1,970
| -89% | -$1.66M | ﹤0.01% | 3481 |
|
|
2014
Q1 | $3.62M | Buy |
+2,214
| New | +$3.62M | ﹤0.01% | 2985 |
|